Avoiding Pitfalls in the Interpretation of Gadoxetic acid (cas 135326-11-3)–Enhanced Magnetic Resonance Imaging

Add time:08/13/2019    Source:sciencedirect.com

Gadoxetic acid is extensively used in the following 3 main clinical situations: characterization of small nodules in patients with cirrhosis, preoperative staging of liver metastases, and characterization of incidentally discovered focal liver lesions. Owing to the rapid entry of gadoxetic acid into hepatocytes, the traditional features of liver tumors are modified on magnetic resonance (MR) imaging, especially during delayed phase sequences. Thus, although the added value of gadoxetic acid for the detection and characterization of focal liver lesions is now clear, its unique pharmacokinetics as well as the presence of mimicking and atypical lesions may lead to misdiagnoses. The goal of this article is to illustrate common and uncommon pitfalls associated with the use of gadoxetic acid–enhanced MR imaging. Moreover, additional MR imaging features that can help establish a correct diagnosis are described.

We also recommend Trading Suppliers and Manufacturers of Gadoxetic acid (cas 135326-11-3). Pls Click Website Link as below: cas 135326-11-3 suppliers

Prev:Gadoxetic acid (cas 135326-11-3)-enhanced dynamic magnetic resonance imaging using optimized integrated combination of compressed sensing and parallel imaging technique
Next:Biliary tract enhancement in Gadoxetic acid (cas 135326-11-3)-enhanced MRI correlates with liver function biomarkers)